US Stock MarketDetailed Quotes

KURA Kura Oncology

Watchlist
  • 16.720
  • -0.250-1.47%
Close Oct 31 16:00 ET
1.28BMarket Cap-7497P/E (TTM)

Kura Oncology Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-66.02%-42.53M
-36.16%-48.84M
-13.41%-124.82M
-29.32%-34.31M
-38.16%-29.03M
15.57%-25.62M
-11.47%-35.87M
-5.27%-110.06M
-13.54%-26.53M
14.57%-21.01M
Net income from continuing operations
-36.75%-50.84M
-45.37%-49.53M
-12.36%-152.63M
-29.21%-42.79M
-8.73%-38.6M
-6.92%-37.17M
-4.98%-34.07M
-4.12%-135.84M
-1.13%-33.11M
-6.41%-35.5M
Depreciation and amortization
-5.16%202K
13.59%234K
11.86%849K
3.88%214K
11.92%216K
16.39%213K
16.38%206K
36.02%759K
24.10%206K
20.63%193K
Other non cash items
4.96%127K
6.09%122K
553.42%477K
--119K
--122K
--121K
--115K
-81.70%73K
----
----
Change In working capital
-51.20%3.1M
32.41%-4.92M
362.21%7.82M
2,309.74%3.71M
-33.51%5.04M
307.59%6.35M
4.96%-7.28M
7.51%-2.98M
-90.36%154K
478.32%7.58M
-Change in prepaid assets
30.86%2.46M
-3.79%-2.19M
33.22%-1.96M
-287.43%-2.53M
-12.28%800K
173.30%1.88M
19.81%-2.11M
-722.13%-2.94M
19.54%1.35M
34.51%912K
-Change in payables and accrued expense
-101.22%-50K
41.69%-3.13M
1,387.66%10.33M
590.13%7.65M
-38.08%3.93M
1,306.16%4.11M
-2.15%-5.36M
68.15%-802K
-5,132.26%-1.56M
4,468.35%6.35M
-Change in other current assets
70.03%539K
24.86%231K
-219.96%-685K
-524.06%-1.46M
19.48%276K
388.18%317K
76.19%185K
273.56%571K
-17.27%345K
-46.53%231K
-Change in other current liabilities
336.36%144K
1,200.00%169K
-25.54%137K
264.71%62K
-65.06%29K
189.19%33K
-89.26%13K
1,020.00%184K
-10.53%17K
36.07%83K
Cash from discontinued investing activities
Operating cash flow
-66.02%-42.53M
-36.16%-48.84M
-13.41%-124.82M
-29.32%-34.31M
-38.16%-29.03M
15.57%-25.62M
-11.47%-35.87M
-5.27%-110.06M
-13.54%-26.53M
14.57%-21.01M
Investing cash flow
Cash flow from continuing investing activities
193.18%43.17M
-956.65%-95.34M
-52.32%15.56M
189.17%42.2M
-88.08%8.56M
-239.97%-46.33M
144.58%11.13M
125.72%32.63M
-163.89%-47.32M
218.52%71.81M
Net PPE purchase and sale
83.33%-16K
-133.33%-84K
73.16%-168K
-33.33%-16K
94.75%-20K
47.83%-96K
26.53%-36K
45.42%-626K
88.24%-12K
47.30%-381K
Net investment purchase and sale
193.41%43.18M
-953.14%-95.25M
-52.71%15.73M
189.23%42.21M
-88.12%8.58M
-238.91%-46.23M
144.82%11.17M
126.46%33.25M
-163.79%-47.31M
210.26%72.19M
Cash from discontinued investing activities
Investing cash flow
193.18%43.17M
-956.65%-95.34M
-52.32%15.56M
189.17%42.2M
-88.08%8.56M
-239.97%-46.33M
144.58%11.13M
125.72%32.63M
-163.89%-47.32M
218.52%71.81M
Financing cash flow
Cash flow from continuing financing activities
-96.77%3.04M
148.37M
145.77%94.78M
-98.01%691K
-90.45%84K
3,422.22%94.01M
0
1,222.71%38.57M
4,271.91%34.71M
-61.03%880K
Net issuance payments of debt
----
----
--0
----
----
----
----
237.93%10M
----
----
Net common stock issuance
--0
--145.81M
278.53%93.58M
--0
--0
--93.58M
--0
--24.72M
--24.72M
--0
Proceeds from stock option exercised by employees
605.34%3.04M
--2.56M
-72.71%1.21M
21.87%691K
-90.45%84K
-83.85%431K
--0
-0.16%4.42M
-28.59%567K
-61.03%880K
Net other financing activities
----
----
----
----
----
----
----
5.89%-575K
----
----
Cash from discontinued financing activities
Financing cash flow
-96.77%3.04M
--148.37M
145.77%94.78M
-98.01%691K
-90.45%84K
3,422.22%94.01M
--0
1,222.71%38.57M
4,271.91%34.71M
-61.03%880K
Net cash flow
Beginning cash position
53.39%41.51M
-27.96%37.32M
-42.87%51.8M
-68.40%28.74M
24.47%49.12M
-20.51%27.06M
-43.00%51.8M
-72.16%90.67M
130.85%90.94M
0.72%39.47M
Current changes in cash
-83.34%3.68M
116.93%4.19M
62.74%-14.48M
121.92%8.58M
-139.44%-20.38M
306.73%22.07M
56.47%-24.74M
83.45%-38.87M
-176.01%-39.14M
24,627.27%51.68M
End cash Position
-8.02%45.18M
53.39%41.51M
-27.96%37.32M
-27.96%37.32M
-68.40%28.74M
24.47%49.12M
-20.51%27.06M
-43.00%51.8M
-43.00%51.8M
130.85%90.94M
Free cash flow
-65.46%-42.55M
-36.26%-48.93M
-12.92%-124.99M
-29.32%-34.32M
-35.79%-29.05M
15.76%-25.71M
-11.41%-35.91M
-4.72%-110.69M
-13.10%-26.54M
15.51%-21.39M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -66.02%-42.53M-36.16%-48.84M-13.41%-124.82M-29.32%-34.31M-38.16%-29.03M15.57%-25.62M-11.47%-35.87M-5.27%-110.06M-13.54%-26.53M14.57%-21.01M
Net income from continuing operations -36.75%-50.84M-45.37%-49.53M-12.36%-152.63M-29.21%-42.79M-8.73%-38.6M-6.92%-37.17M-4.98%-34.07M-4.12%-135.84M-1.13%-33.11M-6.41%-35.5M
Depreciation and amortization -5.16%202K13.59%234K11.86%849K3.88%214K11.92%216K16.39%213K16.38%206K36.02%759K24.10%206K20.63%193K
Other non cash items 4.96%127K6.09%122K553.42%477K--119K--122K--121K--115K-81.70%73K--------
Change In working capital -51.20%3.1M32.41%-4.92M362.21%7.82M2,309.74%3.71M-33.51%5.04M307.59%6.35M4.96%-7.28M7.51%-2.98M-90.36%154K478.32%7.58M
-Change in prepaid assets 30.86%2.46M-3.79%-2.19M33.22%-1.96M-287.43%-2.53M-12.28%800K173.30%1.88M19.81%-2.11M-722.13%-2.94M19.54%1.35M34.51%912K
-Change in payables and accrued expense -101.22%-50K41.69%-3.13M1,387.66%10.33M590.13%7.65M-38.08%3.93M1,306.16%4.11M-2.15%-5.36M68.15%-802K-5,132.26%-1.56M4,468.35%6.35M
-Change in other current assets 70.03%539K24.86%231K-219.96%-685K-524.06%-1.46M19.48%276K388.18%317K76.19%185K273.56%571K-17.27%345K-46.53%231K
-Change in other current liabilities 336.36%144K1,200.00%169K-25.54%137K264.71%62K-65.06%29K189.19%33K-89.26%13K1,020.00%184K-10.53%17K36.07%83K
Cash from discontinued investing activities
Operating cash flow -66.02%-42.53M-36.16%-48.84M-13.41%-124.82M-29.32%-34.31M-38.16%-29.03M15.57%-25.62M-11.47%-35.87M-5.27%-110.06M-13.54%-26.53M14.57%-21.01M
Investing cash flow
Cash flow from continuing investing activities 193.18%43.17M-956.65%-95.34M-52.32%15.56M189.17%42.2M-88.08%8.56M-239.97%-46.33M144.58%11.13M125.72%32.63M-163.89%-47.32M218.52%71.81M
Net PPE purchase and sale 83.33%-16K-133.33%-84K73.16%-168K-33.33%-16K94.75%-20K47.83%-96K26.53%-36K45.42%-626K88.24%-12K47.30%-381K
Net investment purchase and sale 193.41%43.18M-953.14%-95.25M-52.71%15.73M189.23%42.21M-88.12%8.58M-238.91%-46.23M144.82%11.17M126.46%33.25M-163.79%-47.31M210.26%72.19M
Cash from discontinued investing activities
Investing cash flow 193.18%43.17M-956.65%-95.34M-52.32%15.56M189.17%42.2M-88.08%8.56M-239.97%-46.33M144.58%11.13M125.72%32.63M-163.89%-47.32M218.52%71.81M
Financing cash flow
Cash flow from continuing financing activities -96.77%3.04M148.37M145.77%94.78M-98.01%691K-90.45%84K3,422.22%94.01M01,222.71%38.57M4,271.91%34.71M-61.03%880K
Net issuance payments of debt ----------0----------------237.93%10M--------
Net common stock issuance --0--145.81M278.53%93.58M--0--0--93.58M--0--24.72M--24.72M--0
Proceeds from stock option exercised by employees 605.34%3.04M--2.56M-72.71%1.21M21.87%691K-90.45%84K-83.85%431K--0-0.16%4.42M-28.59%567K-61.03%880K
Net other financing activities ----------------------------5.89%-575K--------
Cash from discontinued financing activities
Financing cash flow -96.77%3.04M--148.37M145.77%94.78M-98.01%691K-90.45%84K3,422.22%94.01M--01,222.71%38.57M4,271.91%34.71M-61.03%880K
Net cash flow
Beginning cash position 53.39%41.51M-27.96%37.32M-42.87%51.8M-68.40%28.74M24.47%49.12M-20.51%27.06M-43.00%51.8M-72.16%90.67M130.85%90.94M0.72%39.47M
Current changes in cash -83.34%3.68M116.93%4.19M62.74%-14.48M121.92%8.58M-139.44%-20.38M306.73%22.07M56.47%-24.74M83.45%-38.87M-176.01%-39.14M24,627.27%51.68M
End cash Position -8.02%45.18M53.39%41.51M-27.96%37.32M-27.96%37.32M-68.40%28.74M24.47%49.12M-20.51%27.06M-43.00%51.8M-43.00%51.8M130.85%90.94M
Free cash flow -65.46%-42.55M-36.26%-48.93M-12.92%-124.99M-29.32%-34.32M-35.79%-29.05M15.76%-25.71M-11.41%-35.91M-4.72%-110.69M-13.10%-26.54M15.51%-21.39M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion--------Unqualified Opinion----

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data